Doloromics
Doloromics: A Dallas-based company innovating in pain therapeutics discovery and disease-specific solutions.
Founded
2020Doloromics: A Dallas-based company innovating in pain therapeutics discovery and disease-specific solutions.
Doloromics, founded in Dallas, Texas, is dedicated to revolutionizing pain therapeutics through the discovery of disease-specific pain mechanisms, biomarkers, and therapeutics. The company's core mission is to alleviate chronic pain by developing targeted treatments based on proprietary research and advanced technological platforms. Doloromics focuses on creating innovative solutions that address the underlying causes of pain, aiming to improve the quality of life for patients suffering from various pain-related conditions.
The company has attracted notable investors and experts in the field of biotechnology and pharmaceuticals, contributing to its rapid growth and development. Doloromics has achieved significant milestones in identifying novel pain biomarkers and potential therapeutic targets, positioning itself as a leader in pain management research. The impact of Doloromics' work is evident in its potential to transform pain treatment paradigms, offering hope to millions of patients worldwide who struggle with chronic pain.
Companies similar to Doloromics include XpressiveTech, Concentric Analgesics, Solace Pharmaceuticals and Sarentis Therapeutics.
Doloromics was founded in 2020.
Doloromics' headquarters is located in Menlo Park, CA, US.
Doloromics' most recent funding round was for $6.7M (USD) in February 2022.
As of Feb 1, 2022, Doloromics has disclosed funding of $7.7M (USD). Undisclosed round amounts are excluded.
Doloromics has 7 employees as of Feb 4, 2024.
Sarentis Therapeutics
